Request for information on post-vaccination bioaccumulation of nano particles.
R Bailey made this Official Information request to Ministry of Health
Ministry of Health did not have the information requested.
      From: R Bailey
      
    
    Dear Ministry of Health,
I have recently become aware that lipid nano particles can bioaccumulate in the ovaries of Wistar Rats post vaccination.
Evidence of this is provided in these papers:
"Accumulation of nanocarriers in the ovary: A neglected toxicity risk?"
https://www.sciencedirect.com/science/ar...
And from Pfizer animal studies which have been released under FOIA request in Japan.
"SARS-CoV-2 mRNA Vaccine (BNT162, PF-07302048). 2.6.5"
https://www.pmda.go.jp/drugs/2021/P20210...
I have the following questions:
1A. Is the ministry aware of the information included in these studies showing bioaccumulation in ovaries?
1B If not, why not?
2. If the ministry is aware of the information when did it become aware of the potential of nanolipids particles to accumulate in the ovaries? Who discovered it and who else knew about it.
3. If the ministry is aware, which individual or individuals decided it was not worthy of inclusion on the informed consent information given to the public?
4. Now that the Ministry is presently aware of this information who will decide whether or not it is to be included in future vaccine safety information for informed consent?
Yours faithfully,
R Bailey
        From: OIA Requests
      
    
    Thank you for your Official Information Act request. This is
 an automatic reply to let you know we received it.
In accordance with the Act, we'll let you know our decision within no more
 than 20 working days. If you'd like to calculate the timeframe, you can
 use the Ombudsman's online calculator
 here: [1]http://www.ombudsman.parliament.nz/
Due to the COVID-19 global pandemic response, the Ministry is experiencing
 significantly higher volumes of queries and requests for information. This
 means we may take some time in responding to your request. The Ministry
 regularly updates information about the COVID-19 situation and publishes
 OIA responses considered to be of public interest:
 [2]https://www.health.govt.nz/about-ministr...
Please also refer to the Unite Against Covid-19 website for copies of
 papers, minutes, and key advice for the decisions the Government has made
 relating to COVID-19.
Sometimes we may need to clarify aspects of a request. You can expect to
 hear from us soon if that is the case here.
Ngā mihi,
OIA Services
Government Services
Office of the Director-General
Ministry of Health
E: [3][email address]
 
 
 
 
show quoted sections
References
Visible links
 1. http://scanmail.trustwave.com/?c=15517&a...
 2. https://www.health.govt.nz/about-ministr...
 3. mailto:[email address]
        From: OIA Requests
      
    
    Kia ora,
 
Thank you for your request for official information. The Ministry's
 reference number for your request is: H202201628
 
As required under the Official Information Act 1982, the Ministry will
 endeavour to respond to your request no later than 20 working days after
 the day your request was received. If you'd like to calculate the
 timeframe, you can use the Ombudsman's online calculator
 here: [1]http://www.ombudsman.parliament.nz/
 
Due to the COVID-19 global pandemic response, the Ministry is experiencing
 significantly higher volumes of queries and requests for information. If
 we are unable to respond to your request within this time frame, we will
 notify you of an extension of that time frame.
 
If you have any queries related to this request, please do not hesitate to
 get in touch.
 
Ngā mihi
 
OIA Services
Government Services
Office of the Director-General
Ministry of Health
E: [2][email address]
 
show quoted sections
        From: OIA Requests
      
    
    Tēnā koe R. Bailey
Thank you for your request under the Official Information Act 1982 (the
 Act) to the Ministry of Health (the Ministry) on 18 February 2022 for
 information related to nano lipid particles. Please find a response to
 each part of your request below:
I have recently become aware that lipid nano particles can bioaccumulate
 in the ovaries of Wistar Rats post vaccination. Evidence of this is 
 provided in these papers:
o "Accumulation of nanocarriers in the ovary: A neglected toxicity
 risk?"[1]https://scanmail.trustwave.com/?c=15517&...
o And from Pfizer animal studies which have been released under FOIA
 request in Japan."SARS-CoV-2 mRNA Vaccine (BNT162, PF-07302048).
 2.6.5"[2]https://scanmail.trustwave.com/?c=15517&...
1A. Is the ministry aware of the information included in these studies
 showing bioaccumulation in ovaries? 1B If not, why not?
2. If the ministry is aware of the information when did it become aware of
 the potential of nano lipids particles to accumulate in the ovaries? Who
 discovered it and who else knew about it?
3. If the ministry is aware, which individual or individuals decided it
 was not worthy of inclusion on the informed consent information given to
 the public?
4. Now that the Ministry is presently aware of this information who will
 decide whether or not it is to be included in future vaccine safety
 information for informed consent?
Of the studies related to nano lipid particles referenced above; one is
 from 2012, and the other was submitted to Japanese Authorities. Please
 note that while the Act allows people to ask for information, it does not
 require the Ministry to create new information, compile information it
 does not hold, or in the case of these parts of your request, to comment
 on studies or provide an opinion. The Act does not support requests where
 a comment or a hypothetical statement is put to it and the Ministry is
 asked to comment on it, couched as a request for official information.
 These parts of your request are therefore refused under section 18(g) of
 the Act as the information is not held by the Ministry and there are no
 grounds for believing it is held by another agency subject to the Act.
Under section 28(3) of the Act, you have the right to ask the Ombudsman to
 review any decisions made under this request. The Ombudsman may be
 contacted by email at: [3][email address] or by calling 0800
 802 602.
Ngā mihi
OIA Services Team
 
[4]Ministry of Health information releases
[5]Unite against COVID-19
 
 
 
show quoted sections
References
Visible links
 1. https://scanmail.trustwave.com/?c=15517&...
 2. https://scanmail.trustwave.com/?c=15517&...
 3. mailto:[email address]
 4. https://www.health.govt.nz/about-ministr...
 5. https://covid19.govt.nz/
Things to do with this request
- Add an annotation (to help the requester or others)
 - Download a zip file of all correspondence (note: this contains the same information already available above).
 

